⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
Form 8-K
sec.gov
BBIO
BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates
globenewswire.com
BBIO
BridgeBio to Participate in May and June Investor Conferences
globenewswire.com
BBIO
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
globenewswire.com
BBIO
Condor Software Launches Advanced Analytics and Dynamic Scenario Suite
prnewswire.com
ACAD
BBIO
MDGL
BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE
globenewswire.com
BBIO
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
globenewswire.com
BBIO
BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ET
globenewswire.com
BBIO
BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White
globenewswire.com
BBIO
Form 8-K
sec.gov
BBOT
BBIO
AMGN